Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Megace

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 14 USDMF, 8 CEP/COS, 3 KDMF, 6 NDC API, 10 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

13 Drugs in Development

13 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

65 FDF Dossiers, 21 FDA Orange Book, 25 Europe, 2 Canada, 17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION;ORAL - 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUSPENSION;ORAL - 125MG/ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 3 Rochem International Inc, 4 SPI Pharma, 7 DKSH, 1 Pharm-RX Chemical, 4 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 Kirsch Pharma, 1 ACG Worldwide, 10 Actylis, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 18 BASF, 2 CD Formulation, 11 Corel Pharma Chem, 6 DFE Pharma, 1 Esteem Industries, 2 Finar, 10 Gangwal Chemicals, 4 Ideal Cures, 3 Ingredion Pharma Solutions, 23 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 15 Roquette, 13 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 3 Silverline Chemicals, 3 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

44 Fillers, Diluents & Binders, 40 Coating Systems & Additives, 37 Thickeners and Stabilizers, 26 Direct Compression, 24 Solubilizers, 23 Granulation, 22 Controlled & Modified Release, 20 Topical, 18 Disintegrants & Superdisintegrants, 17 Parenteral, 13 Lubricants & Glidants, 12 Rheology Modifiers, 11 Taste Masking, 11 Emulsifying Agents, 11 Co-Processed Excipients, 10 Film Formers & Plasticizers, 9 API Stability Enhancers, 7 Chewable & Orodispersible Aids, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 2 Coloring Agents

DIGITAL CONTENT

9 News #PharmaBuzz

9 News #PharmaBuzz

GLOBAL SALES INFORMATION

11 US Medicaid Prescriptions, 18 Regulatory FDF Prices

MARKET PLACE

5 APIs, 4 FDF Dossiers

REF. STANDARDS & IMPURITIES

6 EDQM, 3 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
29/11/2025	Axplora	Germany	Samoh Pharmaceutical Co., Ltd.	20210409-211-J-738	megestrol acetate	2021-04-09	Farmabios SpA@Micro-Macinazione SA@IMS srl@Micro-Macinazione SA	Germany	Via Pavia 1-27027 Gropello Cairoli (PV), Italy@Zona Artigianale 11, 6995 Madonna del Piano, Switzerland@Via Venezia Giulia 23, 20157 Milano@Via Cantonale 4, 6998 Monteggio, Switzerland
29/11/2025	Pfizer Inc	U.S.A	Bansen Co., Ltd.	20221114-211-J-1329	megestrol acetate	2022-11-14	Pharmacia & Upjohn Company LLC	U.S.A	7000 Portage Road, Kalamazoo, Michigan 49001 USA

Megace

Megace

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

26 API Suppliers

14 USDMF

8 CEP/COS

3 KDMF

6 NDC API

10 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

13 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

65 FDF Dossiers

21 FDA Orange Book

25 Europe

2 Canada

17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION;ORAL - 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SUSPENSION;ORAL - 125MG/ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI

3 Rochem International Inc

4 SPI Pharma

7 DKSH

1 Pharm-RX Chemical

4 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

1 Pfanstiehl

4 Kirsch Pharma

1 ACG Worldwide

10 Actylis

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

18 BASF

2 CD Formulation

11 Corel Pharma Chem

6 DFE Pharma

1 Esteem Industries

2 Finar

10 Gangwal Chemicals

4 Ideal Cures

3 Ingredion Pharma Solutions

23 Kerry

3 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

14 Microlex e.U

2 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

1 Novo Excipients

2 Pharmatrans-Sanaq

5 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

15 Roquette

13 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

9 Sigachi Industries

3 Silverline Chemicals

3 The Dow Chemical Company

1 Valens Pharmachem

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

44 Fillers, Diluents & Binders

40 Coating Systems & Additives

37 Thickeners and Stabilizers

26 Direct Compression

24 Solubilizers

23 Granulation

22 Controlled & Modified Release

SUSPENSION;ORAL - 40MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons